The circulating levels of IGFBP-2, NECTIN-2, and PECAM-1 were measured in our cohort of 114 patients with IS, including 56% of CE, 23% of AT, and 21% of ESUS. Here, IGFBP2 is linked to cholesteryl ester measurement.